Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada C Villar

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Toxicology and Applied Pharmacology|March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanismAndrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Journal of Pharmacological and Toxicological Methods|June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studiesJean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry|March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart FailureKenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Medicinal Chemistry|July 11, 2026
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective AntagonistsMagnus Nilsson, Sara J Bonvini, Emelyne Diers, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Toxicology and Applied Pharmacology|March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanismAndrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Journal of Pharmacological and Toxicological Methods|June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studiesJean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry|March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart FailureKenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Medicinal Chemistry|July 11, 2026
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective AntagonistsMagnus Nilsson, Sara J Bonvini, Emelyne Diers, et al.
Pageof 2